Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Synonyms :
Class :
prophylaxis:
Everyone who is 6 months of age and older are recommended by the CDC's ACIP to have an annual influenza vaccination
0.5 mL given intramuscularly as single dose/season
Everyone who is 6 months of age and older are recommended by the CDC's ACIP to have an annual influenza vaccination.
Safety & efficacy were not established
Fluarix Quadrivalent, FluLaval Quadrivalent, Fluzone Quadrivalent, Afluria Quadrivalent: below 6 months
6 months to above 9 years
Fluarix Quadrivalent
Not vaccinated: 0.5 mL given intramuscularly in 2 doses
Previously vaccinated: 0.5 mL given intramuscularly in 1-2 doses
Afluria Quadrivalent, FluLaval Quadrivalent, or Fluzone Quadrivalent
6 to below 36 months and not vaccinated: 0.25 mL or 0.5 mL given intramuscularly in 2 doses
6 to below 36 months and previously vaccinated: 0.5 mL given intramuscularly in 1-2 doses
Above 36 months to below 9 years and not vaccinated: 0.5 mL given intramuscularly in 2 doses
Above 36 months to below 9 years and previously vaccinated: 0.5 mL given intramuscularly in 1-2 doses
Flucelvax Quadrivalent
Above 4 to below 9 years: 0.5 mL given intramuscularly in 1-2 doses
Above 9 years
For all the formulations
0.5 mL given intramuscularly as single dose
prophylaxis:
Everyone who is 6 months of age and older are recommended by the CDC's ACIP to have an annual influenza vaccination.
Safety & efficacy were not established
Fluarix Quadrivalent, FluLaval Quadrivalent, Fluzone Quadrivalent, Afluria Quadrivalent: below 6 months
6 months to above 9 years
Fluarix Quadrivalent
Not vaccinated: 0.5 mL given intramuscularly in 2 doses
Previously vaccinated: 0.5 mL given intramuscularly in 1-2 doses
Afluria Quadrivalent, FluLaval Quadrivalent, or Fluzone Quadrivalent
6 to below 36 months and not vaccinated: 0.25 mL or 0.5 mL given intramuscularly in 2 doses
6 to below 36 months and previously vaccinated: 0.5 mL given intramuscularly in 1-2 doses
Above 36 months to below 9 years and not vaccinated: 0.5 mL given intramuscularly in 2 doses
Above 36 months to below 9 years and previously vaccinated: 0.5 mL given intramuscularly in 1-2 doses
Flucelvax Quadrivalent
Above 4 to below 9 years: 0.5 mL given intramuscularly in 1-2 doses
Above 9 years
For all the formulations
0.5 mL given intramuscularly as single dose
prophylaxis:
Everyone who is 6 months of age and older are recommended by the CDC's ACIP to have an annual influenza vaccination
0.5 mL given intramuscularly as single dose/season
Fluzone High Dose Quadrivalent
Indicated in patients above 65 years
0.5 mL given intramuscularly as single dose/season
ifosfamide decreases the effect of action of influenza virus by antagonism.
when influenza virus vaccine quadrivalent is combined with melphalan the therapeutic efficacy of the vaccine decreases
the influenza virus vaccine quadrivalent, adjuvanted effect of action decreases by antagonism.